Mitsubishi UFJ Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-631	Closed	-$19K	–	839
2016 Q4	$19K	Buy	631 +13	+2%	+$396	﹤0.01%	831
2016 Q3	$18K	Sell	618 -41	-6%	-$1.14K	﹤0.01%	818
2016 Q2	$17K	Sell	659 -55	-8%	-$1.46K	﹤0.01%	825
2016 Q1	$18K	Buy	714 +43	+6%	+$1.18K	﹤0.01%	831
2015 Q4	$24K	Hold	671	–	–	﹤0.01%	835
2015 Q3	$14K	Buy	671 +63	+10%	+$1.62K	﹤0.01%	841
2015 Q2	$17K	Sell	608 -82	-12%	-$2.31K	﹤0.01%	851
2015 Q1	$21K	Hold	690	–	–	﹤0.01%	831
2014 Q4	$22K	Buy	690 +10	+1%	+$325	﹤0.01%	827
2014 Q3	$19K	Sell	680 -200	-23%	-$5.58K	﹤0.01%	831
2014 Q2	$24K	Hold	880	–	–	﹤0.01%	839
2014 Q1	$23K	Hold	880	–	–	﹤0.01%	827
2013 Q4	$25K	Sell	880 -20	-2%	-$635	﹤0.01%	793
2013 Q3	$28K	Hold	900	–	–	﹤0.01%	809
2013 Q2	$29K	Buy	+900	New	+$29.6K	﹤0.01%	789

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mitsubishi UFJ Asset Management's GHDX Position: Q1 2017 in Review

Mitsubishi UFJ Asset Management sold out of Genomic Health, Inc. (GHDX) in Q1 2017, closing a stake of 631 shares — an estimated $19K sold.

Mitsubishi UFJ Asset Management first reported a position in GHDX in Q2 2013 and held it in 15 quarters. The position peaked at $29K in Q2 2013. 124 funds tracked by Wall St. Rank hold GHDX as of Q1 2017.

Mitsubishi UFJ Asset Management reported no remaining Genomic Health, Inc. position as of Q1 2017 after selling out during the quarter.
Mitsubishi UFJ Asset Management sold 631 Genomic Health, Inc. shares in Q1 2017, an estimated $19K.
Mitsubishi UFJ Asset Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 15 quarters.
Mitsubishi UFJ Asset Management's Genomic Health, Inc. position peaked at $29K in Q2 2013.
124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2017.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2017, filed 1 May 2017.